To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Having grown GenesisCare’s business in Europe through acquisitions and partnerships, KKR is selling its 45% stake in the Sydney-based healthcare provider to China Resources Group and Macquarie Capital in a deal that reportedly values the company at A$1.7bn.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Copyright PEI Media
Not for publication, email or dissemination